Certificate under Regulation 74 (5) of SEBI (DP) Regulations, 2018 for the quarter ended on 31st March, 2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Genomic Valley Biotech Ltd has filed a compliance certificate confirming that its Registrar and Share Transfer Agent, Beetal Financial & Computer Services Pvt Ltd, properly handled all dematerialization requests during Q4 (January-March 2026). The certificate verifies that securities received for dematerialization were confirmed to depositories (NSDL/CDSL), listed securities remain on stock exchanges, and share certificates were mutilated and cancelled with depositories substituted as registered owners within the required 15-day timeframe. This is a routine regulatory filing required quarterly under SEBI regulations to ensure proper handling of share dematerialization processes.
This is a standard regulatory compliance filing with no direct impact on stock price or shareholder value. It confirms the company follows proper dematerialization procedures as mandated by SEBI.